Photo of Chia-Lun Chang

View Scopus Profile

Chia-Lun Chang

Assistant Professor

  • 380 Citations
  • 13 h-Index
20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2000-2007 M.D., School of Medicine, National Cheng Kung University

Experience

  • Director, Division of Hematology & Oncology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
  • Attending Physician, Division of Hematology & Oncology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
  • 2018.06- Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
  • 2010.08-2012.07 Chief Resident Physician, Linkou Chang Gung Memorial Hospital
  • 2007.08-2010.07 Resident Physician, Linkou Chang Gung Memorial Hospital

Fingerprint Dive into the research topics where Chia-Lun Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

新聘教師研究補助

Chang, C.

11/1/18 → 10/31/20

Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty

雙打擊在瀰漫大B細胞淋巴瘤所扮演的角色-致病機轉與臨床特色之探討-MCL1蛋白在雙打擊瀰漫大B細胞淋巴瘤的表現及其臨床的角色

Chang, C.

1/1/19 → 12/1/19

Project: A - Government Institution › d - Ministry of Education

Research Output

  • 380 Citations
  • 13 h-Index
  • 32 Article
  • 1 Comment/debate
  • 1 Letter

Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells

Liao, C. H., Tzeng, Y. T., Lai, G. M., Chang, C. L., Hu, M. H., Tsai, W. L., Liu, Y. R., Hsia, S., Chuang, S. E., Chiou, T. J., Wang, L. M., Whang-Peng, J. & Yao, C. J., Jul 29 2020, In : Marine Drugs. 18, 8

Research output: Contribution to journal › Article

Open Access

    • Outcomes of adjuvant oral versus intravenous fluoropyrimidines for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

    Zhang, J., Yen, Y. C., Qin, L., Chang, C. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Jan 1 2020, In : Journal of Cancer. 11, 14, p. 4157-4165 9 p.

    Research output: Contribution to journal › Article

    Open Access

    • Adjuvant therapy for high-risk stage ii or iii colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

    Chang, C. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Dec 2019, In : Cancers. 11, 12, 2003.

    Research output: Contribution to journal › Article

    Open Access

    • Hematuria induced by combination regorafenib and hyperthermia–a radiation recall effect

    Zheng, Y. M., Chow, J. M., Chang, C. L., Chao, L. H., Whang-Peng, J. & Lai, G. M., Jan 1 2019, In : International Journal of Hyperthermia. 36, 1, p. 1186-1189 4 p.

    Research output: Contribution to journal › Letter

    Open Access

    Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma

    Hsiao, P-K., Chang, C-L., Yuan, K. S-P., Wu, A. T. H. & Wu, S-Y., Apr 16 2019, In : Journal of Clinical Medicine. 8, 4

    Research output: Contribution to journal › Article